Janus Henderson Group PLC Orchard Therapeutics PLC Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.86 - $5.07 $2.61 Million - $3.43 Million	-676,753 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $1.66 Million - $2.61 Million	-404,201 Reduced 37.39%	676,753 $2.78 Million
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $586,885 - $1.22 Million	102,067 Added 10.43%	1,080,954 $6.49 Million
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $5.44 Million - $15.1 Million	963,397 Added 6219.48%	978,887 $7.37 Million
Q4 2019 Feb 18, 2020	BUY	$10.15 - $15.58 $157,223 - $241,334	15,490 New	15,490 $213,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.